Actualités Leica Biosystems | Leica Biosystems

Updates about Leica Biosystems.

Filter by post category:

Quality

Automated Histology Workflow

Academic Research

Digital Pathology

Translational Research

Tumor Microenvironment

Immunofluorescence

Chromogenic Multiplexing

Biotechnology Industry

Pharmaceutical Industry

Laboratory Technology

Cell & Gene Therapies

Cell and Gene Therapy

Fundamental Research

Delivering Greater Throughput and Decreased Turnaround Time for Research Labs is the Focus of Leica Biosystems Next Generation Digital Pathology Scanner

Published: 9 August 2019

VISTA, CA – Aug 9, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced today that it has launched the Aperio GT 450, its next generation digital pathology scanner. The Aperio GT 450, labeled as research use only, offers continuous rack loading with priority…

Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary Diagnosis

Published: 29 May 2019

VISTA, CA –May 29, 2019 – Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S. A multi-center study supporting this…

Leica Biosystems Receives US Patent for RTF Extreme Speed Scanning Technology

Published: 7 January 2019

VISTA, CA – January 7th, 2019 – Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has granted it a patent for RTF, its breakthrough “Real-Time Focusing” technology (US patent 9,841,590). This will enable high volume, extremely fast line…